KMTS
Kestra Medical Technologies, Ltd.
31.63
+2.08 (+7.04%)
52w low 17.34
31.91 high
98.1% of range
Financial Analysis
| Ratio | Apr 25 | Jul 25 | Oct 25 | Jan 26 | Apr 26 | Jul 26 | Trend |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross Margin | -- | 45.7% | 50.6% | 52.6% | 54.8% | 56.5% | |
| Operating Margin | -- | -149.1% | -140.7% | -141.6% | -137.4% | -121.6% | |
| EBITDA Margin | -- | -112.8% | -126.2% | -123.2% | -120.4% | -127.4% | |
| Net Margin | -- | -133.3% | -145.3% | -139.2% | -135.6% | -142.3% | |
| FCF Margin | -- | -178.3% | -114.5% | -115.5% | -99.1% | -131.2% | |
| Returns | |||||||
| Return on Equity | -- | -14.0% | -20.0% | -11.9% | -15.0% | -19.8% | |
| Return on Assets | -- | -9.7% | -13.3% | -9.0% | -10.8% | -12.7% | |
| Return on Inv Capital | -- | -10.6% | -15.0% | -9.8% | -12.2% | -14.3% | |
| Liquidity | |||||||
| Current Ratio | -- | 6.84x | 5.47x | 7.32x | 4.41x | 4.69x | |
| Quick Ratio | -- | 6.63x | 5.27x | 7.16x | 4.28x | 4.53x | |
| Cash Ratio | -- | 6.24x | 4.91x | 6.79x | 1.98x | 1.42x | |
| Leverage | |||||||
| Debt / Equity | -- | 0.24x | 0.27x | 0.16x | 0.18x | 0.34x | |
| Net Debt / EBITDA | -- | -- | -- | -- | -- | -0.10x | |
| Interest Coverage | -- | -12.49x | -16.23x | -17.08x | -19.96x | -21.83x | |
| Equity Multiplier | -- | 1.45x | 1.50x | 1.32x | 1.38x | 1.56x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.07x | 0.09x | 0.06x | 0.08x | 0.09x | |
| Inventory Turnover | -- | 1.55x | 1.61x | 1.71x | 1.93x | 1.81x | |
| Effective Tax Rate | -- | -0.1% | -0.1% | -0.1% | -0.5% | -0.1% | |
| Op CF / Net Income | -- | 1.02x | 0.56x | 0.54x | 0.48x | 0.73x | |
| Investment | |||||||
| Capex / Revenue | -- | 42.7% | 33.2% | 40.7% | 33.7% | 26.9% | |
| R&D / Revenue | -- | 20.7% | 21.6% | 20.3% | 19.7% | 21.9% | |
| SG&A / Revenue | -- | 174.1% | 169.7% | 173.9% | 172.5% | 156.1% | |
Revenue CAGR
+12.4%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+8.1%